Bacteroides and NAFLD: pathophysiology and therapy

Bacteroides and NAFLD: pathophysiology and therapy

Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver condition observed globally, with the potential to progress to non-alcoholic steatohepatitis (NASH), cirrhosis, and even hepatocellular carcinoma. Currently, the US Food and Drug Administration (FDA) has not approved any drugs fo...

Full description

Bibliographic Details
Main Authors:	Jun Zhang, Jing Zhou, Zheyun He, Hongshan Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Microbiology
Subjects:	Bacteroides NAFLD steatosis liver inflammation intestinal barrier
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2024.1288856/full

Similar Items

Role of Oxidative Stress and Lipid Peroxidation in the Pathophysiology of NAFLD
by: Marta Martín-Fernández, et al.
Published: (2022-11-01)

Association between the cardiometabolic index and NAFLD and fibrosis
by: Laisha Yan, et al.
Published: (2024-06-01)

Imaging and immunometabolic phenotyping uncover changes in the hepatic immune response in the early phases of NAFLD
by: Ariane Barros Diniz, et al.
Published: (2020-08-01)

Correlation between ZJU index and hepatic steatosis and liver fibrosis in American adults with NAFLD
by: Shuang Luo, et al.
Published: (2024-08-01)

Bacteroides acidifaciens and its derived extracellular vesicles improve DSS-induced colitis
by: Cihua Zheng, et al.
Published: (2023-11-01)

HFD and HFD-provoked hepatic hypoxia act as reciprocal causation for NAFLD via HIF-independent signaling
by: Xiaofang Zhang, et al.
Published: (2020-11-01)

Bacteroides fragilis Protects Against Antibiotic-Associated Diarrhea in Rats by Modulating Intestinal Defenses
by: Wendi Zhang, et al.
Published: (2018-05-01)

Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
by: Vera Francisco, et al.
Published: (2022-08-01)

Premenopausal Syndrome and NAFLD: A New Approach Based on Gender Medicine
by: Livianna Carrieri, et al.
Published: (2022-05-01)

NAFLD and HBV interplay - related mechanisms underlying liver disease progression
by: Evanthia Tourkochristou, et al.
Published: (2022-12-01)

The relationship between NAFLD with diet and exercise: Current perspectives
by: Fariba Aghaei
Published: (2022-12-01)

Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial
by: Giuseppe Derosa, et al.
Published: (2022-05-01)

Bacteroides fragilis capsular polysaccharide A ameliorates ulcerative colitis in rat by recovering intestinal barrier integrity and restoring gut microbiota
by: Yijia Zhong, et al.
Published: (2024-12-01)

Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Margalida Monserrat-Mesquida, et al.
Published: (2023-04-01)

Enterotoxigenic and nontoxigenic Bacteroides fragilis strains isolated in Brazil
by: Karla R Miranda, et al.
Published: (2008-11-01)

Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
by: Manfredi Rizzo, et al.
Published: (2023-03-01)

Extraction and Evaluation of Outer Membrane Vesicles from Two Important Gut Microbiota Members, Bacteroides fragilis and Bacteroides thetaiotaomicron
by: Sara Ahmadi Badi, et al.
Published: (2020-10-01)

Non-alcoholic fatty liver disease (NAFLD) is associated with dynamic changes in DNA hydroxymethylation
by: Marcus J. Lyall, et al.
Published: (2020-02-01)

Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
by: Xiaofan Jiang, et al.
Published: (2020-07-01)

Nutrient niche specificity for glycosaminoglycans is reflected in polysaccharide utilization locus architecture of gut Bacteroides species
by: Annelieke Overbeeke, et al.
Published: (2022-11-01)

Usefulness of the SAF score to characterize NAFLD/NASH in non-cirrhotic HCV patients
by: Ahmed El Ray, et al.
Published: (2022-08-01)

Relationship between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients
by: Alihan Oral, et al.
Published: (2019-09-01)

Acupuncture improved hepatic steatosis in HFD-induced NAFLD rats by regulating intestinal microbiota
by: Haiying Wang, et al.
Published: (2023-03-01)

The contribution of the gut-liver axis to the immune signaling pathway of NAFLD
by: Jiayi Liu, et al.
Published: (2022-08-01)

Modulation of satiety hormones by Bacteroides thetaiotaomicron, Bacteroides fragilis and their derivatives
by: Somayeh Vaezijoze, et al.
Published: (2025-03-01)

The Role of the Bacteroides spp. in Bacteraemia
by: Wysocki Mateusz, et al.
Published: (2022-03-01)

Case report: NAFLD and maple syrup urine disease: Is there an interplay between branched-chain amino acids and fructose consumption?
by: Helena Moreira-Silva, et al.
Published: (2022-10-01)

Bacteroides xylanisolvens possesses a potent anti-hyperuricemia effect in goslings fed on a high-protein diet
by: Ning Song, et al.
Published: (2023-06-01)

Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review
by: Siti Aishah Sulaiman, et al.
Published: (2022-12-01)

Bacteroid Development, Transcriptome, and Symbiotic Nitrogen-Fixing Comparison of Bradyrhizobium arachidis in Nodules of Peanut (Arachis hypogaea) and Medicinal Legume Sophora flavescens
by: Wen Feng Chen, et al.
Published: (2023-02-01)

Iron metabolism mediates the relationship between Vitamin C and hepatic steatosis and fibrosis in NAFLD
by: Zhengyu Hu, et al.
Published: (2022-09-01)

Growth Characteristics of Sheep-Derived <i>Bacteroides fragilis</i> and Preliminary Research on Effects in Mice and Lambs
by: Cheng Cheng, et al.
Published: (2025-01-01)

Naringenin prevents NAFLD in the diet-induced C57BL/6J obesity model by regulating the intestinal barrier function and microbiota
by: Ruyang Yu, et al.
Published: (2023-06-01)

Systemic multiomics evaluation of the therapeutic effect of Bacteroides species on liver cirrhosis in male mice
by: Ye Rin Park, et al.
Published: (2023-12-01)

Ultrasound Methods for the Assessment of Liver Steatosis: A Critical Appraisal
by: Dorotea Bozic, et al.
Published: (2022-09-01)

Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Wesam Bahitham, et al.
Published: (2024-02-01)

Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary
by: Rosanna Villani, et al.
Published: (2023-03-01)

The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B
by: Xianhua Mao, et al.
Published: (2023-07-01)

Association of nutrient intake with non-alcoholic fatty liver disease and liver steatosis in adult Indian population – A case control study
by: Swapna Chaturvedi, et al.
Published: (2023-06-01)

The role of intestinal disbiosis in the development of mitochondrial dysfunction and nonalcoholic fatty liver disease
by: P. V. Seliverstov, et al.
Published: (2018-04-01)